In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N¹,N³-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide

Asmaa F. KassemDepartment of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Division, National Research Centre, Giza, Egypt;

Gaber O. MoustafaDepartment of Peptide Chemistry, Chemical Industries Research Division, National Research Centre, Cairo, Egypt; Correspondence[email protected]

Eman S. NossierDepartment of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt;

Hemat S. KhalafDepartment of Chemistry, College of Science and Arts, Jouf University, Al Qurayat, Saudi Arabia; ;Chemical Industries Research Division, Department of Photochemistry, National Research Centre, Cairo, Egypt;

Marwa M. MounierPharmaceutical and Drug Industries Research Division, Department of Pharmacognosy, National Research Centre, Giza, Egypt;

Suliman A. Al-YousefDepartment of Clinical Laboratory Science, College of Applied Medical Science, University of Hafr Al Batin, Hafr Al Batin, Saudi Arabia;

Sabry Y. MahmoudDepartment of Biology, College of Science, University of Hafr Al Batin, Hafr Al Batin, Saudi Arabia

show all

In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N¹,N³-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N1,N3-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N¹,N³-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide